Famciclovir

泛昔洛韦

Report date: 2025/04/18 08:54:34
NME

Base Information

Drug NameFamciclovir
Drug Alias Name法昔洛韦famciclovirum泛昔洛伟泛西洛维Famvir +[9] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 5 DNA polymerase inhibitorsHuman herpesvirus 1 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsDermatitis, AtopicMultiple SclerosisMeniere Disease +[8] 
Global Approved IndicationsHerpes ZosterHerpes SimplexHerpes Genitalis
Approved Indications in ChinaHerpes ZosterHerpes Genitalis
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaPanamaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Medical Co LtdAkeso Pharmaceuticals IncAtnahs Pharma Uk Ltd +[4] 
Inactive CompaniesAkesobio Australia Pty LtdHouse Ear InstituteEms +[6] 
Active IndicationsDermatitis, AtopicHerpes ZosterHerpes Genitalis
Inactive IndicationsMultiple SclerosisMeniere DiseaseChickenpox +[5] 

Other Information

ATC CodeJ05AB09S01AD07
Related LinksWikipediaDrugBankKEGG